Fund shareholders of Summit Therapeutics Inc
ISIN US86627T1088 · United States
- Fund shareholders
- 166
- Of which ETFs
- 44 122 other funds
- Value held
- ≈ 583.3M $ 581.1M $ · 1.1M € · 8.1M SEK
- Share of capital
- 4.8 % of 797.7M shares on Jul 17, 2026
166 funds hold this company. This table lists the 165 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. The “Fund reports” tab lists it, with its weight.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 7,453,137 | 108.6M $ | 1.01 % | 0.93 % | as of Jun 30, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3,707,548 | 54M $ | 0.00 % | 0.46 % | as of Jun 30, 2026 ↗ |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 2,667,317 | 38.9M $ | 0.02 % | 0.33 % | as of Jun 30, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 2,652,737 | 46.5M $ | 0.05 % | 0.33 % | as of May 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 2,531,231 | 36.9M $ | 0.31 % | 0.32 % | as of Jun 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,778,361 | 25.9M $ | 0.03 % | 0.22 % | as of Jun 30, 2026 ↗ |
| VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS | 1,691,382 | 24.6M $ | 0.04 % | 0.21 % | as of Jun 30, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 1,067,669 | 18.7M $ | 0.36 % | 0.13 % | as of May 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 955,912 | 13.9M $ | 0.15 % | 0.12 % | as of Jun 30, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 800,000 | 14M $ | 0.24 % | 0.10 % | as of May 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 797,519 | 14M $ | 0.03 % | 0.10 % | as of May 31, 2026 ↗ |
| iShares Russell Mid-Cap Growth ETF iShares Trust | 791,547 | 11.5M $ | 0.05 % | 0.10 % | as of Jun 30, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 778,918 | 13.7M $ | 0.05 % | 0.10 % | as of May 31, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 659,283 | 11.6M $ | 0.05 % | 0.08 % | as of May 31, 2026 ↗ |
| iShares Russell Mid-Cap ETF iShares Trust | 554,624 | 8.1M $ | 0.01 % | 0.07 % | as of Jun 30, 2026 ↗ |
| iShares Russell 1000 Growth ETF iShares Trust | 515,771 | 7.5M $ | 0.01 % | 0.06 % | as of Jun 30, 2026 ↗ |
| Fidelity Mid Cap Index Fund Fidelity Salem Street Trust | 515,199 | 6.7M $ | 0.01 % | 0.06 % | as of Jul 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 471,305 | 8.3M $ | 0.03 % | 0.06 % | as of May 31, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 462,390 | 8.1M $ | 0.04 % | 0.06 % | as of May 31, 2026 ↗ |
| Schwab U.S. Mid-Cap ETF SCHWAB STRATEGIC TRUST | 416,668 | 7.3M $ | 0.05 % | 0.05 % | as of May 31, 2026 ↗ |
| Invesco NASDAQ Next Gen 100 ETF Invesco Exchange-Traded Fund Trust II | 400,245 | 7M $ | 0.63 % | 0.05 % | as of May 31, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 400,000 | 5.2M $ | 0.17 % | 0.05 % | as of Jul 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 298,393 | 5.2M $ | 0.00 % | 0.04 % | as of May 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 276,987 | 4.9M $ | 0.08 % | 0.03 % | as of May 29, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 252,586 | 3.3M $ | 0.67 % | 0.03 % | as of Jul 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 234,470 | 4.1M $ | 0.00 % | 0.03 % | as of May 31, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 216,018 | 3.1M $ | 0.00 % | 0.03 % | as of Jun 30, 2026 ↗ |
| Goldman Sachs Equal Weight U.S. Large Cap Equity ETF Goldman Sachs ETF Trust | 196,432 | 3.4M $ | 0.19 % | 0.02 % | as of May 31, 2026 ↗ |
| VANGUARD RUSSELL 1000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 193,100 | 3.4M $ | 0.01 % | 0.02 % | as of May 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 191,092 | 3.4M $ | 0.03 % | 0.02 % | as of May 31, 2026 ↗ |
| JNL/T. Rowe Price Mid-Cap Growth Fund JNL Series Trust | 186,044 | 2.7M $ | 0.06 % | 0.02 % | as of Jun 30, 2026 ↗ |
| Fidelity Large Cap Growth Index Fund Fidelity Salem Street Trust | 177,830 | 2.3M $ | 0.01 % | 0.02 % | as of Jul 31, 2026 ↗ |
| Schwab U.S. Large-Cap ETF SCHWAB STRATEGIC TRUST | 175,386 | 3.1M $ | 0.00 % | 0.02 % | as of May 31, 2026 ↗ |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. T. ROWE PRICE DIVERSIFIED MID-CAP GROWTH FUND, INC. | 170,544 | 2.5M $ | 0.05 % | 0.02 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 158,867 | 2.3M $ | 0.31 % | 0.02 % | as of Jun 30, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 145,000 | 2.1M $ | 0.18 % | 0.02 % | as of Jun 30, 2026 ↗ |
| Fidelity Mid Cap Growth Index Fund Fidelity Salem Street Trust | 144,385 | 2.1M $ | 0.05 % | 0.02 % | as of Jun 30, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 121,097 | 2.1M $ | 1.21 % | 0.02 % | as of May 31, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 110,173 | 1.4M $ | 0.00 % | 0.01 % | as of Jul 31, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 102,422 | 1.3M $ | 0.00 % | 0.01 % | as of Jul 31, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 100,167 | 1.5M $ | 0.00 % | 0.01 % | as of Jun 30, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 93,014 | 1.6M $ | 0.00 % | 0.01 % | as of May 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 90,467 | 1.2M $ | 0.00 % | 0.01 % | as of Jul 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 84,610 | 1.1M $ | 0.00 % | 0.01 % | as of Jul 31, 2026 ↗ |
| iShares Russell 1000 ETF iShares Trust | 81,560 | 1.2M $ | 0.00 % | 0.01 % | as of Jun 30, 2026 ↗ |
| iShares U.S. Healthcare ETF iShares Trust | 79,256 | 1M $ | 0.03 % | 0.01 % | as of Jul 31, 2026 ↗ |
| Schwab U.S. Large-Cap Value ETF SCHWAB STRATEGIC TRUST | 79,133 | 1.4M $ | 0.01 % | 0.01 % | as of May 31, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 70,875 | 922.8K $ | 0.78 % | 0.01 % | as of Jul 31, 2026 ↗ |
| iShares Morningstar Mid-Cap Growth ETF iShares Trust | 70,422 | 916.9K $ | 0.02 % | 0.01 % | as of Jul 31, 2026 ↗ |
| Large Cap Index Master Portfolio Master Investment Portfolio | 69,598 | 1M $ | 0.00 % | 0.01 % | as of Jun 30, 2026 ↗ |
| Nuveen Large Cap Growth Index Fund TIAA-CREF Funds | 66,729 | 868.8K $ | 0.00 % | 0.01 % | as of Jul 31, 2026 ↗ |
| iShares Russell 2500 ETF iShares Trust | 64,977 | 946.7K $ | 0.03 % | 0.01 % | as of Jun 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 63,052 | 918.7K $ | 0.00 % | 0.01 % | as of Jun 30, 2026 ↗ |
| LVIP T. Rowe Price Structured Mid-Cap Growth Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 61,900 | 901.9K $ | 0.06 % | 0.01 % | as of Jun 30, 2026 ↗ |
| JPMorgan BetaBuilders U.S. Mid Cap Equity ETF J.P. Morgan Exchange-Traded Fund Trust | 58,622 | 763.3K $ | 0.04 % | 0.01 % | as of Jul 31, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 57,599 | 749.9K $ | 0.03 % | 0.01 % | as of Jul 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 56,004 | 816K $ | 0.32 % | 0.01 % | as of Jun 30, 2026 ↗ |
| JNL/Mellon Healthcare Sector Fund JNL Series Trust | 54,933 | 800.4K $ | 0.03 % | 0.01 % | as of Jun 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 54,882 | 799.6K $ | 0.00 % | 0.01 % | as of Jun 30, 2026 ↗ |
| Schwab 1000 Index Fund SCHWAB INVESTMENTS | 51,020 | 664.3K $ | 0.00 % | 0.01 % | as of Jul 31, 2026 ↗ |
| Biotechnology Fund Rydex Series Funds | 49,916 | 727.3K $ | 0.53 % | 0.01 % | as of Jun 30, 2026 ↗ |
| Handelsbanken Global Småbolag Index Criteria Handelsbanken Fonder AB | 44,600 | 8.1M SEK | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOLIO STATE STREET INSTITUTIONAL INVESTMENT TRUST | 43,600 | 635.3K $ | 0.02 % | 0.01 % | as of Jun 30, 2026 ↗ |
| Invesco Russell 1000 Equal Weight ETF Invesco Exchange-Traded Fund Trust II | 42,970 | 753.7K $ | 0.09 % | 0.01 % | as of May 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 41,569 | 729.1K $ | 1.08 % | 0.01 % | as of May 31, 2026 ↗ |
| VY(R) T. ROWE PRICE DIVERSIFIED MID CAP GROWTH PORTFOLIO Voya Partners Inc | 40,300 | 587.2K $ | 0.06 % | 0.01 % | as of Jun 30, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 39,654 | 577.8K $ | 0.33 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Inspire 500 ETF Northern Lights Fund Trust IV | 34,572 | 606.4K $ | 0.07 % | 0.00 % | as of May 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 32,957 | 480.2K $ | 0.98 % | 0.00 % | as of Jun 30, 2026 ↗ |
| iShares Russell 3000 ETF iShares Trust | 31,284 | 455.8K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| BlackRock Advantage SMID Cap Fund, Inc. BlackRock Advantage SMID Cap Fund, Inc. | 29,953 | 436.4K $ | 0.04 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 28,664 | 502.8K $ | 0.68 % | 0.00 % | as of May 31, 2026 ↗ |
| Schwab U.S. Mid-Cap Index Fund SCHWAB CAPITAL TRUST | 27,017 | 351.8K $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD ESG U.S. STOCK ETF VANGUARD WORLD FUND | 26,355 | 462.3K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 26,125 | 458.2K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| John Hancock Multifactor Mid Cap ETF John Hancock Exchange-Traded Fund Trust | 25,493 | 371.4K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| iShares Russell Mid-Cap Index Fund BlackRock Funds | 24,774 | 322.6K $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| iShares Russell Small/Mid-Cap Index Fund BlackRock Funds | 24,460 | 318.5K $ | 0.02 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 23,553 | 306.7K $ | 0.07 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust | 22,605 | 329.4K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 22,288 | 324.7K $ | 0.03 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 22,185 | 288.8K $ | 0.62 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Schwab U.S. Large-Cap Growth Index Fund SCHWAB CAPITAL TRUST | 19,729 | 256.9K $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD TAX-MANAGED BALANCED FUND VANGUARD TAX-MANAGED FUNDS | 19,524 | 284.5K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| BNY Mellon US Mid Cap Core Equity ETF BNY Mellon ETF Trust | 19,071 | 248.3K $ | 0.04 % | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD RUSSELL 1000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 18,632 | 326.8K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| SIIT EXTENDED MARKET INDEX FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 17,600 | 308.7K $ | 0.02 % | 0.00 % | as of May 31, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 16,728 | 243.7K $ | 0.06 % | 0.00 % | as of Jun 30, 2026 ↗ |
| iShares Morningstar Mid-Cap ETF iShares Trust | 15,238 | 198.4K $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| LVIP Blended Mid Cap Managed Volatility Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 15,200 | 221.5K $ | 0.03 % | 0.00 % | as of Jun 30, 2026 ↗ |
| NYLIM Candriam U.S. Mid Cap Equity ETF NYLIM ETF Trust | 14,813 | 192.9K $ | 0.06 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Diversified Equity Alpha Master Portfolio Master Investment Portfolio | 13,450 | 196K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| iShares Morningstar Growth ETF iShares Trust | 13,322 | 173.5K $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Schwab 1000 Index ETF SCHWAB STRATEGIC TRUST | 13,098 | 229.7K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 12,559 | 183K $ | 0.03 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Columbia Research Enhanced Core ETF Columbia ETF Trust I | 12,006 | 156.3K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| EQ/Large Cap Growth Index Portfolio EQ Advisors Trust | 11,985 | 174.6K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 11,950 | 174.1K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Mid-Cap Index Fund T. ROWE PRICE INDEX TRUST, INC. | 11,924 | 173.7K $ | 0.03 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Global Atlantic BlackRock Disciplined Mid Cap Growth Portfolio Forethought Variable Insurance Trust | 10,902 | 158.8K $ | 0.06 % | 0.00 % | as of Jun 30, 2026 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 0.70 % | as of Sep 30, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| LAGO ERIE, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 1.36 % | as of Dec 31, 2025 ↗ |
| Tema Oncology ETF Tema ETF Trust | 1.21 % | as of May 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 1.08 % | as of May 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 1.01 % | as of Jun 30, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.98 % | as of Jun 30, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 0.78 % | as of Jul 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.77 % | as of Dec 31, 2025 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 0.70 % | as of Sep 30, 2025 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 0.68 % | as of May 31, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 0.67 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 162 | -1 | 37,972,970 | -3.7 % |
| 2026Q2 | 163 | -10 | 39,424,224 | -5.2 % |
| 2026Q1 | 173 | 0 | 41,579,277 | +21.2 % |
| 2025Q4 | 173 | -19 | 34,307,598 | +12.5 % |
| 2025Q3 | 192 | -26 | 30,502,278 | -9.7 % |
| 2025Q2 | 218 | +37 | 33,781,435 | +7.1 % |
| 2025Q1 | 181 | +15 | 31,541,381 | +10.8 % |
| 2024Q4 | 166 | +38 | 28,462,542 | -6.2 % |
| 2024Q3 | 128 | +8 | 30,351,670 | -8.2 % |
| 2024Q2 | 120 | +24 | 33,056,019 | +78.1 % |
| 2024Q1 | 96 | +7 | 18,555,239 | +15.8 % |
| 2023Q4 | 89 | 16,029,010 |
Institutional managers
216 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | 36,391,063 | 690M $ | as of Mar 31, 2026 |
| FMR LLC | 10,853,199 | 205.8M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 9,653,758 | 183M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 8,277,859 | 156.9K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 7,028,160 | 133.3M $ | as of Mar 31, 2026 |
| UBS Group AG | 3,680,315 | 69.8M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,315,854 | 62.9M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 2,242,229 | 42.5M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,650,591 | 31.3M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 1,323,179 | 24M $ | as of Mar 31, 2026 |
| APEIRON CAPITAL Ltd | 1,309,141 | 24.8M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 981,185 | 18.6M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 960,867 | 18.2M $ | as of Mar 31, 2026 |
| TD Asset Management Inc | 956,894 | 18.1M $ | as of Mar 31, 2026 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 892,873 | 16.9M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 784,186 | 14.9M $ | as of Mar 31, 2026 |
| Rock Springs Capital Management LP | 710,000 | 13.5M $ | as of Mar 31, 2026 |
| Aberdeen Group plc | 665,364 | 12.6M $ | as of Mar 31, 2026 |
| Squarepoint Ops LLC | 613,877 | 11.6M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 603,933 | 11.5M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 598,692 | 11.4M $ | as of Mar 31, 2026 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 592,810 | 11.2M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 581,600 | 11M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 548,335 | 10.4M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 540,662 | 10.3M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of Summit Therapeutics Inc". https://titelia.com/en/stocks/summit-therapeutics-inc-US86627T1088